Russell Frank Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$26.1M Sell
187,099
-109,019
-37% -$15.2M 0.05% 476
2015
Q4
$56.7M Buy
296,118
+3,149
+1% +$602K 0.1% 235
2015
Q3
$45.8M Sell
292,969
-8,526
-3% -$1.33M 0.09% 253
2015
Q2
$54.5M Buy
301,495
+59,361
+25% +$10.7M 0.09% 257
2015
Q1
$42M Buy
242,134
+67,472
+39% +$11.7M 0.08% 300
2014
Q4
$32.3M Buy
174,662
+13,896
+9% +$2.57M 0.06% 380
2014
Q3
$26.7M Sell
160,766
-30,370
-16% -$5.04M 0.05% 439
2014
Q2
$31.7M Buy
191,136
+74,054
+63% +$12.3M 0.06% 379
2014
Q1
$17.8M Buy
117,082
+68,597
+141% +$10.4M 0.03% 599
2013
Q4
$7.7M Sell
48,485
-44,012
-48% -$6.99M 0.01% 986
2013
Q3
$10.7M Sell
92,497
-21,421
-19% -$2.49M 0.02% 862
2013
Q2
$10.5M Buy
+113,918
New +$10.5M 0.02% 827